# Rice Bran Supplementation in Treated HIV Infection

> **NCT02922907** · NA · COMPLETED · sponsor: **University of Southern California** · enrollment: 24 (actual)

## Conditions studied

- Inflammation in HIV Infection

## Interventions

- **DIETARY_SUPPLEMENT:** arabinoxylan rice bran
- **DIETARY_SUPPLEMENT:** Placebo for arabinoxylan rice bran

## Key facts

- **NCT ID:** NCT02922907
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-24
- **Primary completion:** 2018-12-03
- **Final completion:** 2019-12-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922907, "Rice Bran Supplementation in Treated HIV Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02922907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*